"Rubella is usually mild in children. But for some peopleā”especially pregnant women and their babiesā”rubella can be serious. Make sure you and your child are protected from rubella by getting vaccinated on schedule.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
MENINGOCOCCAL POLYSACCHARIDE VACCINE - SUBCUTANEOUS INJECTION
COMMON BRAND NAME(S): Menomune
USES: This vaccine helps to protect high-risk patients against a certain type of serious bacterial infection that affects the brain and spinal cord (meningitis). This medication is also used to control an outbreak of this infection if it occurs. This vaccine does not protect you against all strains of this type of bacteria.
Vaccines work by causing the body to produce its own protection (antibodies). Enough antibodies to protect you are usually produced within 7-10 days after you receive this vaccine.
HOW TO USE: Read the Vaccine Information Statement available from your health care provider before receiving the vaccine. If you have any questions, consult your health care provider.
This vaccine is given by injection only under the skin (subcutaneously) by a healthcare professional.
You may need to have another dose of vaccine if you are still at high risk for infection 2-3 years after your last shot. Ask your doctor for more details.
This medication can be given at the same time as most other vaccines, using separate injection sites and separate syringes. However, it must not be given at the same time as whole-cell pertussis or typhoid vaccines.
Additional Menomune Information
Report Problems to the Food and Drug Administration
Find out what women really need.